Loading
No description yet: the sentence for this tag has not been written. 8 records carry it: 8 terms.
| Cancers | Other tags | ||||
|---|---|---|---|---|---|
Antibody isotypes and Fc silencing An antibody's class and the design of its stem change how it connects to immune cells and complement. Switching off one connection does not switch off all of them, and does not make the finished drug harmless. | none | none | none | ||
Antibody structure (Fab, Fc and hinge) An antibody has tips that find a target and a stem that can connect to other parts of the immune system. Two antibodies can reach the same target and do different jobs. | none | none | none | ||
Antibody-guided effector mechanisms (ADCC, ADCP, CDC) An antibody that coats a cell can lead to its removal in three different ways: immune cells that kill it, cells that swallow it, or blood proteins that damage its membrane. Seeing the coat does not show which of these happened. | none | none | none | ||
Antigen-processing machinery (APM) Cells cut up proteins, move some fragments to a loading site and place them on display molecules that T cells can inspect. Having a protein inside a cell does not guarantee its fragment is shown. | none | none | none | ||
B cells, plasmablasts and plasma cells B cells recognise a target and can develop into cells that make large amounts of antibody. A cell's presence tells you little about what its antibody recognises or whether it helps against a cancer. | none | none | none | ||
HLA (human leukocyte antigen) and MHC HLA molecules sit on cells and hold up small pieces of the cell's proteins for T cells to inspect. A T cell reads the fragment together with the particular HLA version holding it. | none | none | none | ||
HLA allele names and typing reports HLA typing reads the inherited versions of the genes that display protein fragments. The name tells you how precisely the version is known, not whether a tumour still shows a given fragment. | none | none | none | ||
Tumour-associated antigen (TAA) A tumour-associated antigen is a target that is common in a tumour but can also be present in healthy tissue. A treatment aimed at it can affect both, and can also react with a different, look-alike target. | none | none | none |